Raymond James Financial
PROF

Raymond James Financial’s Profound Medical PROF Stock Holding History

Raymond James Financial’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
189,116
+38,959
+26% +$262K ﹤0.01% 3831
2026
Q1 		$973K Buy
150,157
+14,872
+11% +$103K ﹤0.01% 3869
2025
Q4 		$1.06M Sell
135,285
-16,226
-11% -$104K ﹤0.01% 3732
2025
Q3 		$741K Sell
151,511
-790,368
-84% -$4.03M ﹤0.01% 3868
2025
Q2 		$5.56M Buy
941,879
+49,000
+5% +$259K ﹤0.01% 2307
2025
Q1 		$5.2M Buy
892,879
+17,170
+2% +$119K ﹤0.01% 2303
2024
Q4 		$6.58M Buy
+875,709
New +$6.72M ﹤0.01% 2145

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Raymond James Financial's PROF Position: Q2 2026 in Review

Raymond James Financial increased its Profound Medical (PROF) stake by 26% in Q2 2026, buying an estimated $262K and bringing the position to 189,116 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #3831.

Raymond James Financial first reported a position in PROF in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.58M in Q4 2024. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Raymond James Financial held 189,116 shares of Profound Medical worth $1.26M as of Q2 2026.
  • Raymond James Financial bought 38,959 Profound Medical shares in Q2 2026, an estimated $262K.
  • Profound Medical made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3831 holding.
  • Raymond James Financial first reported a position in Profound Medical in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Profound Medical position peaked at $6.58M in Q4 2024.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.